The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 TrialDavid Grimwade(King's College School), Anthony P. Goldstone(Hammersmith Hospital)BloodOctober 1, 199810.1182/blood.v92.7.2322Cited by 2,636SaveCiteExport RISWatch citationsRelated PapersDiagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel|Blood|2016|5.9kDiagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet|Blood|2009|3.4kRefinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials|Blood|2010|1.9kMinimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party|Blood|2018|1kManagement of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet|Blood|2008|957